The Healthcare Investment Bank
Who we are
Exclusively focused on healthcare, our specialized team offers a depth of expertise and an extensive network, positioning us as the preferred partner for healthcare companies and their investors. Our deep understanding of the complex healthcare industry drives clients to seek our trusted advice and investment solutions.
As of December 31, 2025
-
1460
+
Transactions Completed
-
$
205
B+
Capital Raised
-
$
75
B+
M&A Advisory
How We’re Different
Solely Focused on Healthcare
We develop tailored strategies for each client based on decades of experience across biopharma, digital health, health tech, tools and diagnostics, healthcare services, and medical technology. With expertise spanning all key subsectors of healthcare, our team brings a wealth of knowledge to each transaction. Our senior bankers take pride in leading every step of the way, from deal origination to closing.
Biopharma
As long-standing leaders in the sector, we collaborate with innovators from growth stage biotechs to large-cap pharmaceuticals.
Digital Health & Health Technology
In this fast-growing segment, we work with companies using digital channels and new technologies to improve clinical outcomes, reduce costs and inform healthcare consumers.
Healthcare Services
We partner with the nation’s largest payers and providers, guiding them through financial, technological, and regulatory change.
Medical Technology
Our team brings years of technology experience to partner with MedTech clients to solve their strategic and capital markets needs.
Tools & Diagnostics
With decades of experience in diagnostics and tools, we work with leaders to drive advancements across the fast-growing sector.
Recent Transactions
Featured Insights
PCSK9 Inhibitors: Cost-Effective for Primary Prevention?
Specialty Drug Coverage Predictions with James Chambers, PhD, MPharm, Professor of Medicine, CEVR, Tufts Medical Center
